Young, Carolyn A. http://orcid.org/0000-0003-1745-7720
Rog, David J.
Sharrack, Basil
Tanasescu, Radu
Kalra, Seema
Harrower, Timothy
Tennant, Alan
Mills, Roger J.
,
Young, Carolyn
Rog, David
Sharrack, Basil
Constantinescu, Cris
Kalra, Seema
Majeed, Tahir
Santander, Helen
Harrower, Tim
Leach, Oliver
Nicholas, Richard
Ford, Helen
Woolmore, John
Kipps, Chris
Johnston, Clare
Thorpe, John
Paling, David
Falah, Yasser
Ellis, Cathy
Pinto, Ashwin
Hanemann, C. Oliver
Chandran, Siddharthan
Malaspina, Andrea
Kitley, Jo
Palace, Jacqueline
Fuller, Tracy
Mottram, Pat
Terrett, Helen
Scalfari, Antonio
Funding for this research was provided by:
Multiple Sclerosis Society (C009-16.1)
Article History
Received: 2 February 2023
Accepted: 21 October 2023
First Online: 17 November 2023
Declarations
:
: Approval was obtained from the North West - Greater Manchester West Research Ethics Committee. The procedures used in this study adhere to the tenets of the Declaration of Helsinki.
: Informed consent was obtained from all individual participants included in the study.
: The authors declare no competing interests.
: C. A. Young has received personal compensation for serving on scientific advisory boards, conference support, or speaker honoraria from BMS, Biogen, Celgene, Cytokinetics, GW Pharmaceuticals, Novartis, Roche, and Teva Pharmaceuticals. Non-financial interests: unpaid member of MNDA HRAP, Darby Rimmer MND Foundation, and My Name′5 Doddie Foundation Scientific Advisory Boards. D. J. Rog has received personal compensation for serving on scientific advisory boards, conference support, or speaker honoraria from Biogen, Celgene, Hikma, Janssen, MedDay, Merck Serono, Novartis, Roche, Sanofi, and Teva Pharmaceuticals. Non-financial interests: unpaid member of Steering Groups of Transforming MS For All and the UK MS Pregnancy Register. B. Sharrack has received personal compensation for serving on scientific advisory boards or conference support from Biogen, Serono, Novartis, and Genzyme. R. Tanasescu has received conference support or speaker honoraria from Novartis, Teva, Johnson and Johnson Romania, and Genzyme. S. Kalra has received personal compensation for serving on scientific advisory boards, conference support, or speaker honoraria from Biogen and Novartis. T. P. Harrower has received personal compensation for serving on scientific advisory boards, conference support, or speaker honoraria from Biogen, Ipsen, Allergan, Abbvie, Sanofi, Merz, GW Pharmaceuticals, Novartis, Roche, and Teva. Non-financial interests: President of the East Devon Branch of the MNDA, Founding Director of the British Neurotoxin Network. A. Tennant has nothing to disclose. R. J. Mills has received reimbursement for conference registration fees from Roche, Teva, Novartis, and Biogen.